5,5-Dimethyl-1,3,2-dioxaphosphorinan-2-one

• Catalog No.: 541524
• CAS Number: 4090-60-2
• M. F.: C5H11O3P
• M. W.: 150.112801
• Purity: 96%

SYNONYMS

• Title: 5,5-二甲基-1,3,2-二氧磷杂环己烷-2-酮
• IUPAC name: 5,5-dimethyl-1,3,2λ^5-dioxaphosphinan-2-one
• IUPAC Traditional name: 5,5-dimethyl-1,3,2λ^5-dioxaphosphinan-2-one
• Synonyms: Neopentylglycol hydrogen phosphite; 2,2-Dimethylpropane-1,3-diol cyclic phosphonate; Cyclic 2,2-dimethyltrimethylene phosphonate; Neopentylene phosphite

DATABASE IDS

• PubChem SID: 24878543
• CAS Number: 4090-60-2
• EC Number: 223-832-8

PROPERTIES

• Empirical Formula (Hill Notation): C5H11O3P
• Purity: 96%
• Flash Point: 109 °C
• Flash Point: 228.2 °F
• Melting Point: 51-56 °C(lit.)
• GHS Signal Word: Danger
• GHS Hazard statements: H314
• European Hazard Symbols: Corrosive (C)
• Personal Protective Equipment: Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
• GHS Precautionary statements: P280-P305 + P351 + P338-P310
• RID/ADR: UN 1759 8/PG 3
• Risk Statements: 34
• Safety Statements: 26-36/37/39-45
• Hazard Class: 8
• UN Number: 1759
• Packing Group: 3
• German water hazard class: 3

DETAILS

Description (English)

Packaging
5 g in glass bottle
Application
Reactant for:
• Palladium(I) catalyzed addition of P(O)-H bonds1
• Highly regioselective modified Pudovik addition reaction2
• Radical reactions mediated by manganese(III) acetate3
• Stable cyclic DEPMPO derivatives as mechanistic markers of stereoselective hydroxyl radical adduct formation in biological systems4
• Copper-catalyzed aerobic oxidative dehydrogenative coupling reactions5
• Bisphosphonates/phosphanamidates as anticancer agents6

Description (简体中文)

包装
5 g in glass bottle
Application
Reactant for:
• Palladium(I) catalyzed addition of P(O)-H bonds1
• Highly regioselective modified Pudovik addition reaction2
• Radical reactions mediated by manganese(III) acetate3
• Stable cyclic DEPMPO derivatives as mechanistic markers of stereoselective hydroxyl radical adduct formation in biological systems4
• Copper-catalyzed aerobic oxidative dehydrogenative coupling reactions5
• Bisphosphonates/phosphanamidates as anticancer agents6